Focus Taiwan App

Medigen to recruit 3,700 volunteers for COVID vaccine phase 2 trials

01/06/2021 11:13 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Jan. 6 (CNA) Medigen Vaccine Biologics Corp. (MVC), a Taiwanese company whose COVID-19 vaccine candidate has been approved for second-stage clinical trials, said Wednesday that it will recruit 3,700 volunteers to participate in the trials over the next three months.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.